LOVE_MEDICAL_GROUP_LIMITE - Accounts


Company Registration No. 08872156 (England and Wales)
LOVE MEDICAL GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2021
PAGES FOR FILING WITH REGISTRAR
LOVE MEDICAL GROUP LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 6
LOVE MEDICAL GROUP LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2021
31 August 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Investments
4
1
1
Current assets
Debtors
5
9
9
Investments
6
24,115
13,115
Cash at bank and in hand
108,765
119,875
132,889
132,999
Creditors: amounts falling due within one year
7
(61,608)
(61,608)
Net current assets
71,281
71,391
Total assets less current liabilities
71,282
71,392
Creditors: amounts falling due after more than one year
8
(97,863)
(97,863)
Net liabilities
(26,581)
(26,471)
Capital and reserves
Called up share capital
9
100
100
Profit and loss reserves
(26,681)
(26,571)
Total equity
(26,581)
(26,471)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 August 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

LOVE MEDICAL GROUP LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2021
31 August 2021
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 3 March 2022
J Syson
Director
Company Registration No. 08872156
LOVE MEDICAL GROUP LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2021
- 3 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 September 2019
100
(30,463)
(30,363)
Year ended 31 August 2020:
Profit and total comprehensive income for the year
-
3,892
3,892
Balance at 31 August 2020
100
(26,571)
(26,471)
Year ended 31 August 2021:
Loss and total comprehensive income for the year
-
(110)
(110)
Balance at 31 August 2021
100
(26,681)
(26,581)
LOVE MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2021
- 4 -
1
Accounting policies
Company information

Love Medical Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 1 Willan Enterprise Centre, Fourth Avenue Village, Trafford Park, Stretford, Manchester, M17 1DB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

The accounts have been prepared on a going concern basis. The company had net liabilities of £26,581 at 31st August 2021.

The company continues to be able to meet its debts as they become due and the director continues to support the company by way of a loan that totaled £61,608.22 at 31st August 2021.

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.4
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

LOVE MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2021
1
Accounting policies
(Continued)
- 5 -
1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
1
1
4
Fixed asset investments
2021
2020
£
£
Shares in group undertakings and participating interests
1
1
5
Debtors
2021
2020
Amounts falling due within one year:
£
£
Other debtors
9
9
LOVE MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2021
- 6 -
6
Current asset investments
2021
2020
£
£
Other investments
24,115
13,115
7
Creditors: amounts falling due within one year
2021
2020
£
£
Other creditors
61,608
61,608
8
Creditors: amounts falling due after more than one year
2021
2020
£
£
Amounts owed to group undertakings
97,863
97,863
9
Called up share capital
2021
2020
2021
2020
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Share of £1 each
100
100
100
100
10
Directors' transactions

Dividends totalling £0 (2020 - £0) were paid in the year in respect of shares held by the company's directors.

2021-08-312020-09-01false03 March 2022CCH SoftwareCCH Accounts Production 2021.300No description of principal activityJ Syson088721562020-09-012021-08-31088721562021-08-31088721562020-08-3108872156core:CurrentFinancialInstrumentscore:WithinOneYear2021-08-3108872156core:CurrentFinancialInstrumentscore:WithinOneYear2020-08-3108872156core:Non-currentFinancialInstrumentscore:AfterOneYear2021-08-3108872156core:Non-currentFinancialInstrumentscore:AfterOneYear2020-08-3108872156core:ShareCapital2021-08-3108872156core:ShareCapital2020-08-3108872156core:RetainedEarningsAccumulatedLosses2021-08-3108872156core:RetainedEarningsAccumulatedLosses2020-08-3108872156core:ShareCapital2019-08-3108872156core:RetainedEarningsAccumulatedLosses2019-08-31088721562019-08-3108872156bus:Director12020-09-012021-08-3108872156core:RetainedEarningsAccumulatedLosses2019-09-012020-08-31088721562019-09-012020-08-3108872156core:RetainedEarningsAccumulatedLosses2020-09-012021-08-3108872156core:WithinOneYear2021-08-3108872156core:WithinOneYear2020-08-3108872156core:CurrentFinancialInstruments2021-08-3108872156core:CurrentFinancialInstruments2020-08-3108872156core:Non-currentFinancialInstruments2021-08-3108872156core:Non-currentFinancialInstruments2020-08-3108872156bus:PrivateLimitedCompanyLtd2020-09-012021-08-3108872156bus:SmallCompaniesRegimeForAccounts2020-09-012021-08-3108872156bus:FRS1022020-09-012021-08-3108872156bus:AuditExemptWithAccountantsReport2020-09-012021-08-3108872156bus:FullAccounts2020-09-012021-08-31xbrli:purexbrli:sharesiso4217:GBP